Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
Connective Tissue Unit, Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland.
Respiration. 2019;97(4):284-291. doi: 10.1159/000494328. Epub 2018 Nov 28.
In Ehlers-Danlos syndrome (EDS), a group of monogenic disorders affecting connective tissues, obstructive sleep apnoea (OSA) is highly prevalent in adults. The prevalence of OSA in children with EDS is unknown.
This prospective cross-sectional study aimed at determining the prevalence of OSA in paediatric EDS patients.
Children with EDS (n = 24) were recruited from the Children's Hospital Zurich and matched to healthy controls. Participants completed home respiratory polygraphy and questionnaires (Sleep-Related Breathing Disorder Scale [SRBD], Epworth Sleepiness Scale [ESS], and Child Health Questionnaire [CHQ]). The American Academy of Sleep Medicine criteria were applied for OSA diagnosis (obstructive apnoea-hypopnoea index [oAHI] ≥1/h). Conditional logistic regression was used to compare the prevalence of OSA and to adjust for possible confounding.
OSA was found in 42% of paediatric EDS patients and in 13% of matched controls (OR = 4.5, 95% CI = 0.97-20.83, p = 0.054). The median oAHI was higher in EDS patients than in controls (0.77/h, IQR = 0.19-1.76, vs. 0.24/h, IQR = 0.0-0.60, p < 0.001 adjusted for age, sex, and BMI z-score). EDS patients had lower scores in most CHQ scales and higher SRBD and ESS scores than controls (0.26, IQR = 0.1-0.35, vs. 0.07, IQR = 0-0.19, p = 0.004); 7 ± 4 vs. 5 ± 4, p = 0.033, respectively).
OSA is a previously underestimated EDS-related complication increasing disease burden.
在埃勒斯-当洛斯综合征(EDS)这一组影响结缔组织的单基因疾病中,阻塞性睡眠呼吸暂停(OSA)在成人中发病率很高。患有 EDS 的儿童中 OSA 的患病率尚不清楚。
本前瞻性横断面研究旨在确定儿科 EDS 患者 OSA 的患病率。
从苏黎世儿童医院招募 EDS 患儿(n=24),并与健康对照组相匹配。参与者在家中完成呼吸多导睡眠图和问卷调查(睡眠相关呼吸障碍量表[SRBD]、嗜睡量表[ESS]和儿童健康问卷[CHQ])。应用美国睡眠医学学会标准诊断 OSA(阻塞性呼吸暂停-低通气指数[oAHI]≥1/h)。采用条件逻辑回归比较 OSA 的患病率,并进行可能的混杂因素调整。
42%的儿科 EDS 患者和 13%的匹配对照组存在 OSA(OR=4.5,95%CI=0.97-20.83,p=0.054)。与对照组相比,EDS 患者的 oAHI 中位数更高(0.77/h,IQR=0.19-1.76,vs. 0.24/h,IQR=0.0-0.60,p<0.001,调整年龄、性别和 BMI z 分数后)。与对照组相比,EDS 患者的大多数 CHQ 量表评分较低,SRBD 和 ESS 评分较高(0.26,IQR=0.1-0.35,vs. 0.07,IQR=0-0.19,p=0.004);7±4 vs. 5±4,p=0.033)。
OSA 是一种先前被低估的 EDS 相关并发症,增加了疾病负担。